Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Shares Outstanding (2016 - 2025)

Lipocine's Shares Outstanding history spans 14 years, with the latest figure at $5.4 million for Q3 2025.

  • For Q3 2025, Shares Outstanding rose 1.35% year-over-year to $5.4 million; the TTM value through Sep 2025 reached $5.4 million, up 1.35%, while the annual FY2024 figure was $5.3 million, 0.6% up from the prior year.
  • Shares Outstanding reached $5.4 million in Q3 2025 per LPCN's latest filing, up from $5.4 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $88.5 million in Q2 2022 to a low of $336.0 in Q3 2022.
  • Average Shares Outstanding over 5 years is $21.7 million, with a median of $5.3 million recorded in 2024.
  • Peak YoY movement for Shares Outstanding: crashed 100.0% in 2023, then surged 1591548.81% in 2024.
  • A 5-year view of Shares Outstanding shows it stood at $5.2 million in 2021, then tumbled by 99.99% to $336.0 in 2022, then skyrocketed by 1581992.26% to $5.3 million in 2023, then increased by 0.6% to $5.3 million in 2024, then increased by 1.35% to $5.4 million in 2025.
  • Per Business Quant, the three most recent readings for LPCN's Shares Outstanding are $5.4 million (Q3 2025), $5.4 million (Q2 2025), and $5.4 million (Q1 2025).